AQP1 and arthritic joint disease: Acetazolamide, AQP1 inhibitor, was decreased AQP1 protein level via inhibition of NF-κB activation and subsequent reduction of hind pow swelling in adjuvant-induced arthritis rats, suggesting that attenuation of AQP1 mediates anti-arthritis effect.42